易華錄(300212.SZ)擬吸收合併尚易德
格隆匯 12 月 11日丨易華錄(300212.SZ)公佈,公司第四屆董事會第五十七次會議審議通過了《關於吸收合併北京尚易德科技有限公司的議案》,公司擬採取吸收合併的方式對全資子公司北京尚易德科技有限公司(“尚易德”)進行壓減。
北京尚易德科技有限公司經營範圍:技術開發、技術轉讓、技術諮詢(中介除外)、技術服務;計算機技術培訓(不得面向全國招生);專業承包;計算機系統服務;銷售計算機、計算機軟件及輔助設備、機械設備、電子產品、通訊設備(衞星接收設備除外)、儀器儀表;企業管理諮詢(中介除外);租賃電子設備;會議服務;技術進出口;代理進出口;貨物進出口(國營貿易管理貨物除外);施工總承包、專業承包、勞務分包。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.